“The Basics of SBIR/STTR Grants and other Public & Private Funding Sources For Innovation and Technology” Hosted by: Clinical and Translational Science Center (CTSC) with the Cornell Center for Technology Enterprise and Commercialization (CCTEC) Friday, February 27, 2009 2:00pm‐6:00pm Weill Greenberg Center Conference Center, 1305 York Ave, 2nd Floor 2:00 –2:05 Julianne Imperato‐McGinley, Weill Cornell Medical Welcome, and Introduction to the CTSC
CTSC Program Director College FUNDING SOURCES – SBIR/STTR Grants, Angel Funding, State and Local Public Resources
Moderator: Brian Kelly, PhD, Director, Technology Commercialization and Liaison, CCTEC 2:05‐2:25 Franklin Madison, Technology Industrial and Technology Strategies for successful SBIR/STTR Program Director Assistance proposals; ITAC and NYSTAR resources. Corporation(ITAC) Finding a business partner. 2:25 –2:45 Rosemarie Filart, NIH NCRR National Institutes of Health SBIR/STTR Overview •
Small Business Innovation Research DCRR SBIR STTR Program Officer (NIH) & National Center for •
Small Business Technology Transfer Research Resources (NCRR) New SBIR/STTR Guidelines Success strategies 2:45‐3:00 Lenzie Harcum, Vice President, New York City Economic Economic Development in NYC –
Biosciences. Initiatives & opportunities Biosciences Development Corporation 3:00‐3:10 Q & A 3:10‐3:30 David S. Rose, Chairman New York Angels, Inc.
The current funding environment; perfect your pitch to an angel investor. 3:30‐3:40 Q & A 3:40‐3:45 BREAK COLLABORATING WITH A SMALL BUSINESS ENTERPRISE
Moderator: Brian Kelly, PhD, Director, Technology Commercialization and Liaison, CCTEC 3:45‐4:05 Dr. Nicholas Schiff Weill Cornell Medical The story of his research, invention, funding College ‐ Neurology strategies & sources: IntElect Medical 4:05‐4:25 Robert Gilmour, PhD Cornell University
Successful small business collaboration through multiple SBIR awards: Gene Network Sciences. 4:25‐4:45 Dr. Neil Bander Weill Cornell Medical Business start‐up issues & challenges,
College ‐ Urology Experimental drug mAb J591: BZL Biologics 4:45‐4:55 Q & A 4:55‐5:05 Michael Goldman, Partner Nixon Peabody LLP
Legal guidelines for successful collaborations between researcher & business; CREATE Act. 5:05‐5:10 Viviane Martin, PhD, Associate Memorial Sloan‐Kettering Office of Industrial Affairs Director Cancer Center Emily Rose, PhD, MBA Hunter College Hunter College Enterprise Office 5:10‐5:20 Q & A 5:20 –6:30 Networking Reception In the Great Hall
Sponsored by Nixon Peabody LLP
SBIR/STTR Reviewers who have contributed “Suggestions from SBIR Reviewers” to the handout materials:
Jason Lewis, PhD, Chief, Radiochemistry, Memorial Sloan-Kettering Cancer Center
Adam Savitz, Md, PhD, Assistant Professor of Psychiatry, Weill Cornell Medical College
Donna Rounds, PhD, Director of Technology Development, Hospital for Special Surgery, provided guidance.
This event is supported by the National Institutes of Health (NIH) and National Center for Research Resources (NCRR)
CTSC: Grant UL1-RR024996